This study will be carried out in 2 emergency departments (at the exit of the emergency
room) and 2 external consultations (endocrinology of the CHU FB Monastir and diabetology
consultation, Jemmal hospital).

Patients over 18 years of age with:

Arterial hypertension (hypertension).

Olive Leaf Extracts in the Control of Hypertension

Hypertension

This study will be carried out in 2 emergency departments (at the exit of the emergency
room, patients included in the GR2 study) and 2 external consultations (endocrinology of
the CHU FB Monastir and diabetology consultation, Jemmal hospital).

All the population will benifit of a biological assessment which include:

Complete lipid profile, blood sugar, creatinine

one population will be randomized:

The population of patients with hypertension.

For patients in the hypertension group:

A blood pressure with holter will be carried out for 24 hours .

atherolive-drug

Placebo Atherolive

Efficacy of a Treatment Based on Olive Leaf Extracts in the Control of Cardiovascular Risk Factors:Hypertension

blood pressure reduction on 24 hours holter

clinical proffesor

The patient will be assigned to one of two treatments (atherolive ) using a
computer-generated randomization list (1: 1 allocation). The investigator who has the
randomization code is not involved in other study procedures and does not interact with
participants. The study drug (atherolive) will be prescribed at a dose of 400 mg, once a
day for 3 months.

The patient will be assigned to one of two treatments using a computer-generated
randomization list (1: 1 allocation). The investigator who has the randomization code is
not involved in other study procedures and does not interact with participants. The study
drug (atherolive-placebo) will be prescribed at a dose of 400 mg, once a day for 3
months.

Olive Leaf Extracts in the Control of Hypertension

About this trial

Study ID

Status

Type

Phase

Placebo

Accepting

Not accepting

Trial Timing

What is this trial about?

What are the participation requirements?